v3.19.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 167,436 $ 9,811
Accounts receivable, net 89,991 76,919
Inventories 8,733 8,650
Prepaid assets 9,553 7,727
Other current assets 632 561
Total current assets 276,345 103,668
Property and equipment (net of accumulated depreciation of $59,455 and $50,127, respectively) 59,334 60,888
Operating lease right-of-use assets 26,057  
Intangible assets, net 135,301 140,029
Goodwill 196,298 197,892
Other assets 3,332 2,538
Total assets 696,667 505,015
Current liabilities    
Accounts payable 16,326 17,779
Accrued compensation 19,621 19,062
Accrued expenses and other liabilities 7,893 8,986
Short-term portion of financing obligations 5,825  
Short-term portion of financing obligations   6,298
Short-term portion of operating leases 3,428  
Short-term portion of term loan 5,000 7,873
Pharma contract liability 1,069 927
Total current liabilities 59,162 60,925
Long-term liabilities    
Long-term portion of finance lease obligations 4,782  
Long-term portion of finance lease obligations   5,250
Long-term portion of operating leases 24,179  
Long-term portion of term loans, net 94,250 87,880
Revolving credit facility 0 5,000
Other long term liabilities 4,443 3,060
Deferred income tax liability, net 20,117 22,457
Total long-term liabilities 147,771 123,647
Total liabilities 206,933 184,572
Stockholders' equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 103,834,212 and 94,465,440 shares issued and outstanding, respectively) 104 94
Additional paid-in capital 543,484 372,186
Accumulated other comprehensive loss (2,163) (579)
Accumulated deficit (51,691) (51,258)
Total stockholders’ equity 489,734 320,443
Total liabilities and stockholders' equity $ 696,667 $ 505,015

Source